3D radiation therapy or intensity-modulated radiotherapy for recurrent and metastatic cervical cancer: The Shanghai cancer hospital experience

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Liu, Su Ping ^a   Huang, Xiao ^a   Ke, Gui Hao ^a   Huang, Xiao Wei ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CANCER RADIOTHERAPY; CHINA; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTESTINE OBSTRUCTION; LEUKOPENIA; METASTASIS; MORBIDITY; PROCTITIS; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RECURRENT CANCER; SALVAGE THERAPY; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER;

ADULT; AGED; CANCER CARE FACILITIES; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RADIOTHERAPY, INTENSITY-MODULATED; UTERINE CERVICAL NEOPLASMS;

EID: 84863086351     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040299     Document Type: Article

References (33)

1. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, et al. (1990) Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38: 352-357.
2. Burghardt E, Baltzer J, Tulusan AH, Haas J, (1992) Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 70: 648-655.
3. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, et al. (1991) Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67: 2776-2785.
4. Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, et al. (2004) Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 22: 3113-3119.
5. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, et al. (2009) Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 27: 4649-4655.
6. van NagellJR, Rayburn W Jr, Donaldson ES, Hanson M, Gay EC, et al. (1979) Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer 44: 2354-2361.
7. Jobsen JJ, Leer JW, Cleton FJ, Hermans J, (1989) Treatment of locoregional recurrence of carcinoma of the cervix by radiotherapy after primary surgery. Gynecol Oncol 33: 368-371.
8. Larson DM, Copeland LJ, Stringer CA, Gershenson DM, Malone JM Jr, et al. (1988) Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol 30: 381-387.
9. Deutsch M, Parsons JA, (1974) Radiotherapy for carcinoma of the cervix recurrent after surgery. Cancer 34: 2051-2055.
10. Ito H, Shigematsu N, Kawada T, Kubo A, Isobe K, et al. (1997) Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy. Gynecol Oncol 67: 154-161.
11. Wang CJ, Lai CH, Huang HJ, Hong JH, Chou HH, et al. (1999) Recurrent cervical carcinoma after primary radical surgery. Am J Obstet Gynecol 181: 518-524.
12. Mabuchi S, Isohashi F, Yoshioka Y, Temma K, Takeda T, et al. (2010) Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy. Int J Gynecol Cancer 20: 834-840.
13. Piver MS, Barlow JJ, Krishnamsetty R, (1981) Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. Am J Obstet Gynecol 139: 575-578.
14. Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ, (1998) Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys 41: 817-822.
15. Portelance L, Chao KS, Grigsby PW, Bennet H, Low D, (2001) Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51: 261-266.
16. Du XL, Sheng XG, Jiang T, Yu H, Yan YF, et al. (2010) Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study. Croat Med J 51: 229-236.
17. Ahmed RS, Kim RY, Duan J, Meleth S, De Los Santos JF, et al. (2004) IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys 60: 505-512.
18. Deodato F, Macchia G, Grimaldi L, Ferrandina G, Lorusso D, et al. (2009) Stereotactic radiotherapy in recurrent gynecological cancer: a case series. Oncol Rep 22: 415-419.
19. Guckenberger M, Bachmann J, Wulf J, Mueller G, Krieger T, et al. (2010) Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. Radiother Oncol 94: 53-59.
20. Potish R, Adcock L, Jones T Jr, Levitt S, Prem K, et al. (1983) The morbidity and utility of periaortic radiotherapy in cervical carcinoma. Gynecol Oncol 15: 1-9.
21. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, et al. (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17: 1339-1348.
22. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, et al. (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144-1153.
23. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18: 1606-1613.
24. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, et al. (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340: 1154-1161.
25. Kato T, Nishimura H, Yakushiji M, Noda K, Terashima Y, et al. (1992) [Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer]. Gan To Kagaku Ryoho 19: 695-701.
26. Hartmann JT, Lipp HP, (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4: 889-901.
27. Thigpen T, Vance RB, Khansur T, (1995) The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix. Semin Oncol 22: 67-75.
28. Zhang MQ, Liu SP, Wang XE, (2010) Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study. Int J Radiat Oncol Biol Phys 78: 821-827.
29. Yamazaki A, Shirato H, Nishioka T, Hashimoto S, Kitahara T, et al. (2000) Reduction of late complications after irregularly shaped four-field whole pelvic radiotherapy using computed tomographic simulation compared with parallel-opposed whole pelvic radiotherapy. Jpn J Clin Oncol 30: 180-184.
30. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, et al. (2002) Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52: 1330-1337.
31. Mundt AJ, Mell LK, Roeske JC, (2003) Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 56: 1354-1360.
32. Roeske JC, Bonta D, Mell LK, Lujan AE, Mundt AJ, (2003) A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol 69: 201-207.
33. Brixey CJ, Roeske JC, Lujan AE, Yamada SD, Rotmensch J, et al. (2002) Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54: 1388-1396.